Wedbush PacGrow has focused on servicing the financial needs of public and private healthcare companies for over 25 years. The group specializes in numerous segments of the healthcare industry, including biopharma, medical technology, diagnostics, and life science tools companies at all stages of development. We have a full spectrum of capabilities, including public equity, PIPEs, ATMs, private equity, mergers & acquisitions, and strategic advisory. Our Healthcare Investment Banking professionals have deep healthcare-sector expertise, broad venture and private-equity relationships, and proven capital raising and advisory transaction experience in their sectors.
"As we work to enhance value for our shareholders, we believe it is important to identify and evaluate all options available to us, and believe that Wedbush PacGrow is an ideal partner to advise us in this process,” stated David Renzi, President and CEO of Carbylan Therapeutics. “The Wedbush PacGrow team has many years of proven experience assisting companies in maximizing shareholder value and has been a strong supporter of Carbylan Therapeutics, including as an underwriter in our IPO in April 2015."